FDA Inspection
Sandoz GmbHSandoz GmbH – FDA Inspection, Mar 2, 2018
Record Details
This FDA Inspection record concerns Sandoz GmbH, with an inspection on March 2, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Marion Michaelis (Investigator)
- Michael Shanks (Issuing Officer)
View Company Profile
ID · ed99692f-12a9-40cb-9eb6-1c5fe71b012f
Inspection Facts
- Inspection number
- 1045918
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Sandoz GmbH
8| Date | Classification | Office | Project area |
|---|---|---|---|
| January 12, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 11, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2017 | Not classified | Office of Inspections and Investigations | |
| July 5, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sandoz GmbH
- FDA Inspection 1195376 - 2023-01-12
- FDA Inspection 1205998 - 2022-07-11
- FDA Inspection 1040853 - 2017-10-13
- FDA Inspection 981928 - 2016-07-05
- FDA Inspection 872125 - 2014-03-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.